Biocompatibility, cytotoxicity and antibacterial effects of meropenem-loaded mesoporous silica nanoparticles against carbapenem-resistant Enterobacteriaceae

References

• Memar MY, Ghotaslou R, Samiei M, et al. Antimicrobial use of reactive oxygen therapy: current insights. Infect Drug Resist. 2018;11:567–576.
   PubMed Web of Science ®Google Scholar
• Gupta A, Mumtaz S, Li C-H, et al. Combatting antibiotic-resistant bacteria using nanomaterials. Chem Soc Rev. 2019;48(2):415–427.
   PubMed Web of Science ®Google Scholar
• Barzegari A, Kheyrolahzadeh K, Hosseiniyan Khatibi SM, et al. The battle of probiotics and their derivatives against biofilms. Infect Drug Resist. 2020;13:659–672.
   PubMed Web of Science ®Google Scholar
• Giske CG, Monnet DL, Cars O, et al. Clinical and economic impact of common multidrug-resistant gram-negative bacilli. Antimicrob Agents Chemother. 2008;52(3):813–821.
   PubMed Web of Science ®Google Scholar
• Alhashem F, Tiren-Verbeet NL, Alp E, et al. Treatment of sepsis: what is the antibiotic choice in bacteremia due to carbapenem resistant Enterobacteriaceae? World J Clin Cases. 2017;5(8):324–332.
   PubMed Web of Science ®Google Scholar
• Akhi MT, Ghotaslou R, Beheshtirouy S, et al. Antibiotic susceptibility pattern of aerobic and anaerobic bacteria isolated from surgical site infection of hospitalized patients. Jundishapur J Microbiol. 2015;8(6): e20309.
   Google Scholar
• Alizadeh N, Rezaee MA, Kafil HS, et al. Detection of carbapenem-resistant Enterobacteriaceae by chromogenic screening media. J Microbiol Methods. 2018;153:40–44.
   PubMed Web of Science ®Google Scholar
• Jacob JT, Klein E, Laxminarayan R, et al. Vital signs: carbapenem-resistant Enterobacteriaceae. MMWR. 2013;62(9):165.
   PubMed Web of Science ®Google Scholar
• Wang Q, Zhang Y, Yao X, et al. Risk factors and clinical outcomes for carbapenem-resistant Enterobacteriaceae nosocomial infections. Eur J Clin Microbiol Infect Dis. 2016;35(10):1679–1689.
   PubMed Web of Science ®Google Scholar
• Schwaber MJ, Carmeli Y. Carbapenem-resistant Enterobacteriaceae: a potential threat. Jama. 2008;300(24):2911–2913.
   PubMed Web of Science ®Google Scholar
• Sharifi S, Fathi N, Memar MY, et al. Anti‐microbial activity of curcumin nanoformulations: new trends and future perspectives. Phytother Res. 2020;34(8):1926–1946.
   PubMed Web of Science ®Google Scholar
• Koneru B, Shi Y, Wang Y-C, et al. Tetracycline-containing MCM-41 mesoporous silica nanoparticles for the treatment of Escherichia coli. Molecules. 2015;20(11):19690–19698.
   PubMed Web of Science ®Google Scholar
• Gounani Z, Asadollahi MA, Meyer RL, et al. Loading of polymyxin B onto anionic mesoporous silica nanoparticles retains antibacterial activity and enhances biocompatibility. Int J Pharm. 2018;537(1–2):148–161.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhao Q, Han N, et al. Mesoporous silica nanoparticles in drug delivery and biomedical applications. Nanomedicine. 2015;11(2):313–327.
   PubMed Web of Science ®Google Scholar
• Bharti C, Nagaich U, Pal AK, et al. Mesoporous silica nanoparticles in target drug delivery system: a review. Int J Pharm Investig. 2015;5(3):124–133.
   PubMed Web of Science ®Google Scholar
• Bhar R, Kanwar R, Mehta S. Surface engineering of nanoparticles anchored meso-macroporous silica heterostructure: an efficient adsorbent for DNA. Mater Chem Phys. 2020;255:123541.
   Web of Science ®Google Scholar
• Sunar S. The future potentials of mesoporous silica nanoparticles. J Adv Chem Pharma Mat. 2020;3(2):241–243.
   Google Scholar
• Hanafi-Bojd MY, Jaafari MR, Ramezanian N, et al. Surface functionalized mesoporous silica nanoparticles as an effective carrier for epirubicin delivery to cancer cells. Eur J Pharm Biopharm. 2015;89:248–258.
   PubMed Web of Science ®Google Scholar
• Hanafi-Bojd MY, Ansari L, Mosaffa F, et al. The effect of mesoporous silica nanoparticles loaded with epirubicin on drug-resistant cancer cells. Nanomed J. 2017;4(3):135–141.
   Google Scholar
• Maleki Dizaj S, Lotfipour F, Barzegar-Jalali M, et al. Ciprofloxacin HCl-loaded calcium carbonate nanoparticles: preparation, solid state characterization, and evaluation of antimicrobial effect against Staphylococcus aureus. Artif Cells Nanomed Biotechnol. 2017;45(3):535–543.
   PubMed Web of Science ®Google Scholar
• Weinstein MP. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. National Committee for Clinical Laboratory Standards. 2018; 38(2): 89–92.
   Google Scholar
• Memar MY, Adibkia K, Farajnia S, et al. Biocompatibility, cytotoxicity and antimicrobial effects of gentamicin-loaded CaCO3 as a drug delivery to osteomyelitis. J Drug Delivery Sci Technol. 2019;54:101307.
   Web of Science ®Google Scholar
• Achilli C, Grandi S, Ciana A, et al. Biocompatibility of functionalized boron phosphate (BPO4) nanoparticles for boron neutron capture therapy (BNCT) application. Nanomedicine. 2014;10(3):589–597.
   PubMed Web of Science ®Google Scholar
• Rahimi M, Safa KD, Salehi R. Co-delivery of doxorubicin and methotrexate by dendritic chitosan-g-mPEG as a magnetic nanocarrier for multi-drug delivery in combination chemotherapy. Polym Chem. 2017;8(47):7333–7350.
   Web of Science ®Google Scholar
• Díaz-García D, Ardiles P, Prashar S, et al. Preparation and study of the antibacterial applications and oxidative stress induction of copper maleamate-functionalized mesoporous silica nanoparticles. Pharmaceutics. 2019;11(1):30.
   PubMed Web of Science ®Google Scholar
• Cooper J, Hunt J. The significance of zeta potential in osteogenesis. in Annual Meeting-Society for Biomaterials in Conjunction with the International Biomaterials Symposium. 2006.
   Google Scholar
• Smeets R, Kolk A, Gerressen M, et al. A new biphasic osteoinductive calcium composite material with a negative zeta potential for bone augmentation. Head Face Med. 2009;5(1):13.
   PubMedGoogle Scholar
• Zhao Y, Wang Y, Ran F, et al. A comparison between sphere and rod nanoparticles regarding their in vivo biological behavior and pharmacokinetics. Sci Rep. 2017;7(1):1–11.
   PubMed Web of Science ®Google Scholar
• Geng Y, Dalhaimer P, Cai S, et al. Shape effects of filaments versus spherical particles in flow and drug delivery. Nat Nanotechnol. 2007;2(4):249–255.
   PubMed Web of Science ®Google Scholar
• Li D, Tang Z, Gao Y, et al. A bio‐inspired rod‐shaped nanoplatform for strongly infecting tumor cells and enhancing the delivery efficiency of anticancer drugs. Adv Funct Mater. 2016;26(1):66–79.
   Web of Science ®Google Scholar
• Vega-Jiménez AL, Vázquez-Olmos A, Acosta-Gío E, et al. In vitro antimicrobial activity evaluation of metal oxide nanoparticles. in Nanoemulsions-Properties, Fabrications and Applications. 2019. IntechOpen. 84369.
   Google Scholar
• Kamba SA, Ismail M, Hussein-Al-Ali SH, et al. In vitro delivery and controlled release of doxorubicin for targeting osteosarcoma bone cancer. Molecules. 2013;18(9):10580–10598.
   PubMed Web of Science ®Google Scholar
• Liu Y, Liu X, Xiao Y, et al. A multifunctional nanoplatform based on mesoporous silica nanoparticles for imaging-guided chemo/photodynamic synergetic therapy. RSC Adv. 2017;7(49):31133–31141.
   Web of Science ®Google Scholar
• Seleem MN, Munusamy P, Ranjan A, et al. Silica-antibiotic hybrid nanoparticles for targeting intracellular pathogens. Antimicrob Agents Chemother. 2009;53(10):4270–4274.
   PubMed Web of Science ®Google Scholar
• Braun K, Pochert A, Lindén M, et al. Membrane interactions of mesoporous silica nanoparticles as carriers of antimicrobial peptides. J Colloid Interface Sci. 2016;475:161–170.
   PubMed Web of Science ®Google Scholar
• Chung KT, Wong TY, Wei CI, et al. Tannins and human health: a review. Crit Rev Food Sci Nutr. 1998;38(6):421–464.
   PubMed Web of Science ®Google Scholar
• Samiei M, Farjami A, Dizaj SM, et al. Nanoparticles for antimicrobial purposes in Endodontics: a systematic review of in vitro studies. Mater Sci Eng C Mater Biol Appl. 2016;58:1269–1278.
   PubMed Web of Science ®Google Scholar
• Molina-Manso D, Manzano M, Doadrio JC, et al. Usefulness of SBA-15 mesoporous ceramics as a delivery system for vancomycin, rifampicin and linezolid: a preliminary report. Int J Antimicrob Agents. 2012;40(3):252–256.
   PubMed Web of Science ®Google Scholar
• Wang Y, Nor YA, Song H, et al. Small-sized and large-pore dendritic mesoporous silica nanoparticles enhance antimicrobial enzyme delivery. J Mater Chem B. 2016;4(15):2646–2653.
   PubMed Web of Science ®Google Scholar
• Balaure PC, Boarca B, Popescu RC, et al. Bioactive mesoporous silica nanostructures with anti-microbial and anti-biofilm properties. Int J Pharm. 2017;531(1):35–46.
   PubMedGoogle Scholar
• Carmona D, Lalueza P, Balas F, et al. Mesoporous silica loaded with peracetic acid and silver nanoparticles as a dual-effect, highly efficient bactericidal agent. Microporous Mesoporous Mater. 2012;161:84–90.
   Web of Science ®Google Scholar
• Liong M, France B, Bradley KA, et al. Antimicrobial activity of silver nanocrystals encapsulated in mesoporous silica nanoparticles. Adv Mater. 2009;21(17):1684–1689.
   Web of Science ®Google Scholar
• Lu M-M, Wang Q-J, Chang Z-M, et al. Synergistic bactericidal activity of chlorhexidine-loaded, silver-decorated mesoporous silica nanoparticles. Int J Nanomed. 2017;12:3577–3589.
   PubMed Web of Science ®Google Scholar
• He Q, Zhang J, Shi J, et al. The effect of PEGylation of mesoporous silica nanoparticles on nonspecific binding of serum proteins and cellular responses. Biomaterials. 2010;31(6):1085–1092.
   PubMed Web of Science ®Google Scholar
• Chen Y, Chen H, Zhang S, et al. Multifunctional mesoporous nanoellipsoids for biological bimodal imaging and magnetically targeted delivery of anticancer drugs. Adv Funct Mater. 2011;21(2):270–278.
   Web of Science ®Google Scholar
• Slowing II, Wu C-W, Vivero-Escoto JL, et al. Mesoporous silica nanoparticles for reducing hemolytic activity towards mammalian red blood cells. Small. 2009;5(1):57–62.
   PubMed Web of Science ®Google Scholar
• Dhar S, Mali V, Bodhankar S, et al. Biocompatible gellan gum-reduced gold nanoparticles: cellular uptake and subacute oral toxicity studies. J Appl Toxicol. 2011;31(5):411–420.
   PubMed Web of Science ®Google Scholar
• Murashov V, Harper M, Demchuk E. Impact of silanol surface density on the toxicity of silica aerosols measured by erythrocyte haemolysis. J Occup Environ Hyg. 2006;3(12):718–723.
   PubMed Web of Science ®Google Scholar
• Yu T, Malugin A, Ghandehari H. Impact of silica nanoparticle design on cellular toxicity and hemolytic activity. ACS Nano. 2011;5(7):5717–5728.
   PubMed Web of Science ®Google Scholar
• Menon N, Leong DT. Cytotoxic effects of phosphonate-functionalized mesoporous silica nanoparticles. ACS Appl Mater Interfaces. 2016;8(3):2416–2422.
   PubMed Web of Science ®Google Scholar
• Duan J, Yu Y, Li Y, et al. Toxic effect of silica nanoparticles on endothelial cells through DNA damage response via Chk1-dependent G2/M checkpoint. PLoS One. 2013;8(4):e62087.
   PubMed Web of Science ®Google Scholar
• Napierska D, Thomassen LCJ, Lison D, et al. The nanosilica hazard: another variable entity. Part Fibre Toxicol. 2010;7(1):39.
   PubMed Web of Science ®Google Scholar